A high-affinity fully human anti–IL-6 mAb, 1339, for the treatment of multiple myeloma

M Fulciniti, T Hideshima, C Vermot-Desroches… - Clinical Cancer …, 2009 - AACR
Purpose: We investigated the in vitro and in vivo anti-multiple myeloma activity of
monoclonal antibody (mAb) 1339, a high-affinity fully humanized anti-interleukin 6 mAb (…

Intercellular adhesion molecule-2 (CD102) binds to the leukocyte integrin CD11b/CD18 through the A domain.

…, R Li, P Kotovuori, C Vermot-Desroches… - … (Baltimore, Md.: 1950 …, 1995 - journals.aai.org
The interactions between the leukocyte-specific beta 2-integrins cluster of differentiation (CD)
Ag CD11/CD18 and their ligands, the intercellular adhesion molecules (ICAMs), play …

Akt signaling pathway: a target for radiosensitizing human malignant glioma

…, J Chassagne, C Vermot-Desroches… - Neuro …, 2010 - academic.oup.com
Radiation therapy plays a central role in the treatment of glioblastoma, but it is not curative
due to the high tumor radioresistance. Phosphatidyl-inositol 3-kinase/protein kinase B (Akt) …

Identification of an interleukin-15α receptor-binding site on human interleukin-15

…, A Quéméner, RH Meloen, C Vermot-Desroches… - Journal of Biological …, 2004 - ASBMB
To identify the epitopes in human interleukin-15 (IL-15) that are responsible for binding to
the interleukin-15 receptor α chain, antibody and receptor mapping by peptide scanning and …

[HTML][HTML] Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Rα2 as a decoy receptor for IL13

J Bernard, D Treton, C Vermot-Desroches… - Laboratory …, 2001 - Elsevier
Glioma and renal cell carcinoma (RCC) cells express high affinity interleukin 13 (IL13) binding
sites, but only RCC cell proliferation was inhibited by IL13. Both of these two cell types …

Dual epitope targeting and enhanced hexamerization by DR5 antibodies as a novel approach to induce potent antitumor activity through DR5 agonism

…, A Ortiz Buijsse, C Vermot-Desroches… - Molecular Cancer …, 2020 - AACR
Higher-order death receptor 5 (DR5) clustering can induce tumor cell death; however,
therapeutic compounds targeting DR5 have achieved limited clinical efficacy. We describe …

Heterogeneity of antigen expression among human umbilical cord vascular endothelial cells: identification of cell subsets by co-expression of haemopoietic antigens

C Vermot-Desroches, D Marchand, C Roy, J Wijdenes - Immunology letters, 1995 - Elsevier
First described as an interface between blood and tissues, the endothelial cells are now known
to be also involved in haemostasis, inflammatory and immune responses. Recent studies …

Silent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia

…, D Bouige, P Thomare, C Vermot-Desroches… - Leukemia & …, 2010 - Taylor & Francis
This prospective study aimed to assess the incidence of silent hypersensitivity to
Escherichia coli asparaginase in the treatment of acute lymphoblastic leukemia (ALL). Thirty-three …

Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2

…, C Crouin, C Guenzi, C Vermot-Desroches… - Biochemical …, 2004 - portlandpress.com
Gab2 (Grb2-associated binder-2), a member of the IRS (insulin receptor substrate)/Gab family
of adapter proteins, undergoes tyrosine phosphorylation in response to cytokine or growth …

Lymphoma and Myeloma Cell Resistance to Cytotoxic Agents and Ionizing Radiations Is Not Affected by Exposure to Anti–IL-6 Antibody

…, A Mansuy, JY Blay, L Alberti, C Vermot-Desroches - PloS one, 2009 - journals.plos.org
Background Production of high levels of IL-6 is often correlated with resistance to cytotoxics
or ionizing radiations, in cancer cell lines as in various cancer patients. We investigated …